Article Details
Retrieved on: 2019-03-14 12:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Brookline Capital Management restated a “buy” rating on shares of Rexahn Pharmaceuticals in ... to its most recent 13F filing with the Securities and Exchange Commission. ... The correct version of this piece can be accessed at https://pressoracle.com/news/2019/03/15/<b>cboe</b>-<b>global</b>-<b>markets</b>-cboe-rating- ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here